Charmaine Roson - Philippines

“Mark your calendars with these new deadlines. After a reprieve during the early pandemic, this should be the final implementation schedule for newly regulated medical devices in the Philippines.”

Charmaine Roson
Principal Consultant
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines Extends Grace Period for Non-Notified Class B, C, and D Medical Device Registration

Published on: August 17th, 2021

Non-Notified Products can be Imported without a CMDN through March 2022

With the release of Circular No. 2021-002-A, “Addendum to FDA Circular No. 2021-002” on August 8th, the FDA formalized new guidelines for the final transition phases in the Philippines for the pre-market registration requirement for all medical devices.

Now, during the grace period, Class B, C, and D medical devices that are not included in the specified list in Circular No. 2021-001-A may continue to be manufactured, imported/exported, distributed, and/or sold without an initial Certificate of Medical Device Notification (CMDN) until March 31, 2022. The importers of these devices are simply required to have a valid License To Operate (LTO) for importation and tenders. Non-notified devices not yet on the market in the Philippines, must first apply for and be issued a CMDN for importation and sales in the Philippines.

Grace Period Deadline

The new grace period will end on April 1, 2022, and after that, a CMDN or a pending application will be required for manufacturing, importing, distributing, and/or selling in the Philippines. The application window for a CMDN for Class B, C, and D devices is until March 31, 2023 and will end on April 1, 2023, after which a more involved Certificate of Medical Device Registration (CMDR) will be required. CMDNs with validity beyond April 1, 2023, will remain valid until their expiry. Three (3) months prior to the expiration of the CMDN, the company will need to apply for a CMDR and the issued CMDN and proof application for CMDR shall be provided at the point of entry and/or part of bidding requirements until the CMDR is approved.

From April 1, 2023, manufacturers of Class, B, C, and D devices not already registered under the CMDN route, will need to apply for a CMDR.

Regarding Certificates of Exemption (COEs), any that were issued from February 25, 2014 will be valid until March 31, 2022 to facilitate applications for CMDNs.

The Addendum will take effect 15 days after publication.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia and with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests for the Philippines.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.


On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.